GS Yuasa Corp
TSE:6674
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
1 949.5
3 375
|
Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Balance Sheet
Balance Sheet Decomposition
GS Yuasa Corp
Current Assets | 300.9B |
Cash & Short-Term Investments | 54.3B |
Receivables | 97.9B |
Other Current Assets | 148.7B |
Non-Current Assets | 356.2B |
Long-Term Investments | 76.6B |
PP&E | 206.1B |
Intangibles | 4.8B |
Other Non-Current Assets | 68.8B |
Current Liabilities | 188.5B |
Accounts Payable | 71.8B |
Short-Term Debt | 15.5B |
Other Current Liabilities | 101.2B |
Non-Current Liabilities | 137.4B |
Long-Term Debt | 51.6B |
Other Non-Current Liabilities | 85.8B |
Balance Sheet
GS Yuasa Corp
Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
24 841
|
28 604
|
24 994
|
18 927
|
23 618
|
25 226
|
36 280
|
25 855
|
36 272
|
63 935
|
|
Cash Equivalents |
24 841
|
28 604
|
24 994
|
18 927
|
23 618
|
25 226
|
36 280
|
25 855
|
36 272
|
63 935
|
|
Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Receivables |
78 903
|
72 508
|
71 434
|
79 421
|
74 077
|
75 288
|
78 993
|
92 144
|
104 059
|
110 777
|
|
Accounts Receivables |
78 903
|
72 508
|
71 434
|
79 421
|
74 077
|
75 288
|
78 993
|
92 144
|
104 059
|
110 777
|
|
Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Inventory |
59 913
|
61 130
|
62 838
|
69 742
|
67 826
|
64 291
|
67 867
|
93 050
|
110 069
|
115 011
|
|
Other Current Assets |
12 402
|
13 553
|
13 893
|
11 305
|
10 469
|
10 909
|
11 192
|
15 251
|
15 725
|
27 186
|
|
Total Current Assets |
177 259
|
175 795
|
173 159
|
179 395
|
175 990
|
175 714
|
194 332
|
226 300
|
266 125
|
316 909
|
|
PP&E Net |
124 665
|
117 085
|
124 278
|
122 846
|
124 202
|
127 852
|
134 530
|
143 007
|
165 043
|
188 596
|
|
Intangible Assets |
2 637
|
4 073
|
8 733
|
7 877
|
7 010
|
4 431
|
3 760
|
2 894
|
4 007
|
4 026
|
|
Goodwill |
0
|
0
|
5 599
|
4 349
|
3 347
|
1 995
|
659
|
0
|
1 233
|
1 046
|
|
Note Receivable |
0
|
0
|
225
|
0
|
38
|
2 294
|
3 323
|
3 751
|
3 770
|
2 946
|
|
Long-Term Investments |
44 661
|
46 390
|
48 521
|
56 685
|
57 124
|
55 233
|
66 006
|
67 259
|
64 093
|
80 661
|
|
Other Long-Term Assets |
10 153
|
2 993
|
9 993
|
18 064
|
16 532
|
17 897
|
29 303
|
37 552
|
36 635
|
62 479
|
|
Other Assets |
0
|
0
|
5 599
|
4 349
|
3 347
|
1 995
|
659
|
0
|
1 233
|
1 046
|
|
Total Assets |
359 522
N/A
|
346 523
-4%
|
370 508
+7%
|
389 216
+5%
|
384 243
-1%
|
385 416
+0%
|
431 913
+12%
|
480 763
+11%
|
540 906
+13%
|
656 663
+21%
|
|
Liabilities | |||||||||||
Accounts Payable |
36 682
|
38 460
|
44 254
|
51 648
|
52 275
|
47 670
|
51 109
|
64 035
|
80 557
|
103 075
|
|
Accrued Liabilities |
0
|
105
|
120
|
0
|
112
|
123
|
120
|
120
|
120
|
185
|
|
Short-Term Debt |
21 544
|
20 663
|
11 358
|
13 348
|
11 191
|
8 542
|
6 113
|
17 460
|
30 734
|
28 335
|
|
Current Portion of Long-Term Debt |
11 222
|
3 443
|
16 176
|
29 116
|
1 714
|
6 244
|
9 095
|
5 023
|
23 428
|
9 965
|
|
Other Current Liabilities |
35 026
|
36 601
|
37 912
|
30 545
|
31 447
|
39 436
|
41 402
|
42 738
|
40 473
|
46 970
|
|
Total Current Liabilities |
104 564
|
99 272
|
109 820
|
124 657
|
96 739
|
102 015
|
107 839
|
129 376
|
175 312
|
188 530
|
|
Long-Term Debt |
50 802
|
50 469
|
47 886
|
33 912
|
55 273
|
55 218
|
58 021
|
67 796
|
59 867
|
49 477
|
|
Deferred Income Tax |
12 269
|
8 899
|
12 232
|
11 603
|
12 995
|
11 555
|
18 973
|
20 838
|
21 251
|
31 132
|
|
Minority Interest |
20 801
|
24 066
|
26 432
|
29 863
|
29 388
|
28 982
|
32 324
|
34 705
|
40 213
|
43 888
|
|
Other Liabilities |
9 700
|
10 093
|
12 415
|
13 406
|
11 528
|
11 310
|
12 510
|
12 815
|
13 586
|
13 644
|
|
Total Liabilities |
198 136
N/A
|
192 799
-3%
|
208 785
+8%
|
213 441
+2%
|
205 923
-4%
|
209 080
+2%
|
229 667
+10%
|
265 530
+16%
|
310 229
+17%
|
326 671
+5%
|
|
Equity | |||||||||||
Common Stock |
33 021
|
33 021
|
33 021
|
33 021
|
33 021
|
33 021
|
33 021
|
33 021
|
33 021
|
52 841
|
|
Retained Earnings |
46 498
|
51 399
|
59 501
|
66 822
|
77 664
|
87 180
|
95 869
|
93 661
|
103 503
|
131 542
|
|
Additional Paid In Capital |
54 880
|
55 292
|
55 292
|
55 313
|
55 313
|
55 301
|
55 301
|
55 292
|
53 201
|
74 008
|
|
Unrealized Security Profit/Loss |
11 947
|
0
|
13 166
|
17 110
|
17 016
|
14 070
|
19 308
|
18 317
|
15 967
|
21 663
|
|
Treasury Stock |
341
|
0
|
358
|
1 387
|
2 315
|
3 680
|
4 654
|
351
|
321
|
314
|
|
Other Equity |
15 381
|
3 474
|
1 101
|
4 896
|
2 379
|
9 556
|
3 401
|
15 293
|
25 306
|
50 252
|
|
Total Equity |
161 386
N/A
|
153 724
-5%
|
161 723
+5%
|
175 775
+9%
|
178 320
+1%
|
176 336
-1%
|
202 246
+15%
|
215 233
+6%
|
230 677
+7%
|
329 992
+43%
|
|
Total Liabilities & Equity |
359 522
N/A
|
346 523
-4%
|
370 508
+7%
|
389 216
+5%
|
384 243
-1%
|
385 416
+0%
|
431 913
+12%
|
480 763
+11%
|
540 906
+13%
|
656 663
+21%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
83
|
83
|
83
|
82
|
82
|
81
|
81
|
80
|
80
|
100
|